Koers CHF Solutions Nasdaq
Aandelen
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 8,98 mln. 8,24 mln. | Omzet 2025 * | 10,32 mln. 9,47 mln. | Marktkapitalisatie | 2,18 mln. 2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -10 mln. -9,17 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,26 mln. | EV/omzet 2024 * | 0,24 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,21 x |
K/w-verhouding 2024 * |
-0,13
x | K/w-verhouding 2025 * |
-0,45
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,21% |
Recentste transcriptie over CHF Solutions
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nestor Jaramillo
CEO | Chief Executive Officer | 66 | 07-05-19 |
Robert Scott
DFI | Director of Finance/CFO | 44 | 01-01-13 |
John Erb
CHM | Chairman | 75 | 01-09-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Erb
CHM | Chairman | 75 | 01-09-12 |
Director/Board Member | 61 | 01/11 | |
Gregory Waller
BRD | Director/Board Member | 74 | 03-08-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,64% | 208 mld. | |
+8,99% | 182 mld. | |
+29,83% | 155 mld. | |
+35,17% | 115 mld. | |
+2,55% | 66,52 mld. | |
+15,06% | 53,93 mld. | |
-6,47% | 46,26 mld. | |
-2,14% | 38,22 mld. | |
+6,88% | 36,6 mld. |